Percutaneous Device Closure of Congenital Isolated Ventricular Septal Defects: A Single-Center Retrospective Database Study Amongst 412 Cases.


Journal

Pediatric cardiology
ISSN: 1432-1971
Titre abrégé: Pediatr Cardiol
Pays: United States
ID NLM: 8003849

Informations de publication

Date de publication:
Mar 2020
Historique:
received: 30 09 2019
accepted: 22 01 2020
pubmed: 15 2 2020
medline: 1 9 2020
entrez: 15 2 2020
Statut: ppublish

Résumé

To identify suitable cases and reduce failure/complication rates for percutaneous ventricular septal defect (VSD) closure, we aimed to (1) study causes of device failure and (2) compare outcomes with different VSD types and devices in a high-volume single center with limited resources. Retrospective data of 412 elective percutaneous VSD closure of isolated congenital VSDs between 2003 and 2017 were analyzed. Out of 412, 363 were successfully implanted, in 30 device implantation failed, and in 19 the procedure was abandoned. Outcome was assessed using echocardiography, electrocardiography, and catheterization data (before procedure, immediately after and during follow-up). Logistic regression analyses were performed to assess effects of age, VSD type, and device type and size on procedural outcome. Median [interquartile range] age and body surface area were 6.6 [4.1-10.9] years and 0.7 [0.5-1.0] m

Identifiants

pubmed: 32055941
doi: 10.1007/s00246-020-02315-0
pii: 10.1007/s00246-020-02315-0
pmc: PMC7170976
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

591-598

Références

Cardiol Young. 2010 Oct;20(5):560-1
pubmed: 20836201
Heart Vessels. 2012 Jul;27(4):398-404
pubmed: 21618026
Chin Med J (Engl). 2017 5th Mar;130(5):516-521
pubmed: 28229981
J Thorac Cardiovasc Surg. 2008 Nov;136(5):1223-8
pubmed: 19026807
Eur Heart J. 2006 Dec;27(23):2889-95
pubmed: 17053007
Br Heart J. 1980 Mar;43(3):332-43
pubmed: 7437181
Catheter Cardiovasc Interv. 2015 Nov 15;86(6):1048-56
pubmed: 26257085
J Am Coll Cardiol. 2007 Sep 18;50(12):1189-95
pubmed: 17868812
Front Pediatr. 2018 May 03;6:128
pubmed: 29774208
Eur Heart J. 2007 Oct;28(19):2361-8
pubmed: 17684082

Auteurs

Varsha Walavalkar (V)

Department of Pediatric Cardiology and Grown-Up Congenital Heart Diseases, Narayana Institute of Cardiac Sciences, NH Health City, 258/A, Bommasandra Industrial Area, Anekal Taluk, Bangalore, Karnataka, 560099, India.

Shreesha Maiya (S)

Department of Pediatric Cardiology and Grown-Up Congenital Heart Diseases, Narayana Institute of Cardiac Sciences, NH Health City, 258/A, Bommasandra Industrial Area, Anekal Taluk, Bangalore, Karnataka, 560099, India.

Suresh Pujar (S)

Department of Pediatric Cardiology and Grown-Up Congenital Heart Diseases, Narayana Institute of Cardiac Sciences, NH Health City, 258/A, Bommasandra Industrial Area, Anekal Taluk, Bangalore, Karnataka, 560099, India.

Prakash Ramachandra (P)

Department of Pediatric Cardiology and Grown-Up Congenital Heart Diseases, Narayana Institute of Cardiac Sciences, NH Health City, 258/A, Bommasandra Industrial Area, Anekal Taluk, Bangalore, Karnataka, 560099, India.

Satheesh Siddaiah (S)

Department of Pediatric Cardiology and Grown-Up Congenital Heart Diseases, Narayana Institute of Cardiac Sciences, NH Health City, 258/A, Bommasandra Industrial Area, Anekal Taluk, Bangalore, Karnataka, 560099, India.

Bart Spronck (B)

Department of Biomedical Engineering, School of Engineering & Applied Science, Yale University, New Haven, CT, USA.

Ward Y Vanagt (WY)

Pediatric Cardiology, University Medical Center, Groningen, The Netherlands.
Cardiovascular Research Institute Maastricht CARIM, Maastricht University, Maastricht, The Netherlands.

Tammo Delhaas (T)

Cardiovascular Research Institute Maastricht CARIM, Maastricht University, Maastricht, The Netherlands. tammo.delhaas@maastrichtuniversity.nl.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH